Company / R&D Expense
BIO KEY INTERNATIONAL INC R&D Expense History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$1.7M
FY2017
5-year range
$1.3M / $2.0M
FY2013-FY2017
Trend
-17.4%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 7 years, ranging from $947,371 in FY2012 to $2M in FY2016.
Based on SEC 10-K filings.
$2M in FY2017 with a 5-year CAGR of +11.9%.
Improved from $2M to $2M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +0.7%
- 5-Year CAGR
- +11.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +11.9%, indicating consistent growth.
- In FY2017, r&d expense decreased 17.4% year-over-year.
- Peak r&d expense was recorded in FY2016.
- Lowest r&d expense in the period was in FY2012.
Company context
Key Data Points
- Altman Z-Score -1.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $1.7M | -17.4% |
| FY2016 | $2.0M | +29.1% |
| FY2015 | $1.6M | -4.3% |
| FY2014 | $1.6M | +21.0% |
| FY2013 | $1.3M | +41.9% |
| FY2012 | $947.4K | -15.2% |
| FY2011 | $1.1M | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026